Wealthy investors are making significant bullish bets on Edwards Lifesciences.
Analysis of the options history of Edwards Lifesciences (EW) shows 14 trades have been identified.
Among these trades, 42% of investors are engaging in bullish strategies, while another 42% are taking a bearish approach.
Of the total trades observed, 4 are puts amounting to $169,256, and 10 are calls totaling $439,821.
What is the Price Target?
Based on trading volumes and Open Interest, market influencers are eyeing a price range between $60.0 and $80.0 for Edwards Lifesciences over the past three months.
Examining Volume & Open Interest Trends
Presently, the average open interest for Edwards Lifesciences options stands at 1511.31, with a total volume of 4,213.00. Visual representations show the evolution of call and put option volumes and open interests for significant trades with strike prices between $60.0 and $80.0 in the last 30 days.
An Overview of 30-Day Option Volume & Interest for Edwards Lifesciences
Major Options Activities:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EW | CALL | TRADE | BEARISH | 11/15/24 | $2.05 | $1.8 | $1.8 | $77.50 | $147.0K | 3.5K | 1.2K |
About Edwards Lifesciences
Established following a spin-off from Baxter International in 2000, Edwards Lifesciences specializes in designing, manufacturing, and marketing medical devices for advanced stages of structural heart disease. The company leads in critical products such as surgical tissue heart valves, transcatheter valve technologies, and other cardiovascular devices, with over half of its sales sourced internationally.
Current Position of Edwards Lifesciences in the Market
- Edwards Lifesciences has recorded a trading volume of 6,662,255, with its stock price rising by 4.82% to reach $74.01.
- The current Relative Strength Index (RSI) suggests the stock may be nearing overbought levels.
- The next earnings report is set to be released in the near term.
Expert Perspectives on Edwards Lifesciences
Within the last month, 5 professional analysts have provided insights on Edwards Lifesciences, establishing an average price target of $71.6.
Various analysts from institutions such as Citigroup, Evercore ISI Group, Morgan Stanley, and more have shared their ratings and price targets on Edwards Lifesciences.
Trading options carries substantial risks but also offers the potential for significant gains. Seasoned traders navigate these risks through continuous education, strategic adjustments, and market awareness. For real-time option trade alerts related to Edwards Lifesciences, consider leveraging resources like Benzinga Pro.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
